Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-013071
Filing Date
2022-06-17
Accepted
2022-06-17 16:05:38
Documents
1
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4116
  Complete submission text file 0001567619-22-013071.txt   5490
Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
GLUCK FREDERICK W (Reporting) CIK: 0001184126 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 221023767

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

EIN.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations